- FDA approves daily HIV pill from Gilead designed to simplify treatment for some patients CNBC
- Gilead wins approval of single-pill HIV treatment Bixlenvo - San Francisco Business Times The Business Journals
- U.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults With HIV, Including Those on Complex Regimens Gilead Sciences
- Gilead christens Bixlenvo with FDA nod for new HIV treatment combo tablet Fierce Pharma
- US FDA approves Gilead’s once-daily combination pill for HIV treatment whbl.com
Рекомендовані коментарі
Для публікації повідомлень створіть обліковий запис або авторизуйтесь